Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Issue 7 (July 2021)
- Record Type:
- Journal Article
- Title:
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Issue 7 (July 2021)
- Main Title:
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
- Authors:
- Bloom, Chloe I
Drake, Thomas M
Docherty, Annemarie B
Lipworth, Brian J
Johnston, Sebastian L
Nguyen-Van-Tam, Jonathan S
Carson, Gail
Dunning, Jake
Harrison, Ewen M
Baillie, J Kenneth
Semple, Malcolm G
Cullinan, Paul
Openshaw, Peter J M
Alex, Beatrice
Bach, Benjamin
Barclay, Wendy S
Bogaert, Debby
Chand, Meera
Cooke, Graham S
Filipe, Ana da
Fletcher, Tom
Green, Christoper A
Harrison, Ewen M
Hiscox, Julian A
Ho, Antonia Ying
Horby, Peter W
Ijaz, Samreen
Khoo, Saye
Klenerman, Paul
Law, Andrew
Lim, Wei Shen
Mentzer, Alexander J
Merson, Laura
Meynert, Alison M
Noursadeghi, Mahdad
Moore, Shona C
Palmarini, Massimo
Paxton, William A
Pollakis, Georgios
Price, Nicholas
Rambaut, Andrew
Robertson, David L
Russell, Clark D
Sancho-Shimizu, Vanessa
Scott, Janet T
Silva, Thushan de
Sigfrid, Louise
Solomon, Tom
Sriskandan, Shiranee
Stuart, David
Summers, Charlotte
Tedder, Richard S
Thomson, Emma C
Thompson, AA Roger
Thwaites, Ryan S
Turtle, Lance CW
Zambon, Maria
Hardwick, Hayley
Donohue, Chloe
Lyons, Ruth
Griffiths, Fiona
Oosthuyzen, Wilna
Norman, Lisa
Pius, Riinu
Fairfield, Cameron J
Knight, Stephen R
Mclean, Kenneth A
Murphy, Derek
Shaw, Catherine A
Dalton, Jo
Girvan, Michelle
Saviciute, Egle
Roberts, Stephanie
Harrison, Janet
Marsh, Laura
Connor, Marie
Halpin, Sophie
Jackson, Clare
Gamble, Carrol
Leeming, Gary
Law, Andrew
Wham, Murray
Clohisey, Sara
Hendry, Ross
Scott-Brown, James
Greenhalf, William
Shaw, Victoria
McDonald, Sara
Keating, Seán
Ahmed, Katie A.
Armstrong, Jane A
Ashworth, Milton
Asiimwe, Innocent G
Bakshi, Siddharth
Barlow, Samantha L
Booth, Laura
Brennan, Benjamin
Bullock, Katie
Catterall, Benjamin WA
Clark, Jordan J
Clarke, Emily A
Cole, Sarah
Cooper, Louise
Cox, Helen
Davis, Christopher
Dincarslan, Oslem
Dunn, Chris
Dyer, Philip
Elliott, Angela
Evans, Anthony
Finch, Lorna
Fisher, Lewis WS
Foster, Terry
Garcia-Dorival, Isabel
Greenhalf, William
Gunning, Philip
Hartley, Catherine
Jensen, Rebecca L
Jones, Christopher B
Jones, Trevor R
Khandaker, Shadia
King, Katharine
Kiy, Robyn T.
Koukorava, Chrysa
Lake, Annette
Lant, Suzannah
Latawiec, Diane
Lavelle-Langham, Lara
Lefteri, Daniella
Lett, Lauren
Livoti, Lucia A
Mancini, Maria
McDonald, Sarah
McEvoy, Laurence
McLauchlan, John
Metelmann, Soeren
Miah, Nahida S
Middleton, Joanna
Mitchell, Joyce
Moore, Shona C
Murphy, Ellen G
Penrice-Randal, Rebekah
Pilgrim, Jack
Prince, Tessa
Reynolds, Will
Ridley, P. Matthew
Sales, Debby
Shaw, Victoria E
Shears, Rebecca K
Small, Benjamin
Subramaniam, Krishanthi S
Szemiel, Agnieska
Taggart, Aislynn
Tanianis-Hughes, Jolanta
Thomas, Jordan
Trochu, Erwan
Tonder, Libby van
Wilcock, Eve
Zhang, J. Eunice
Flaherty, Lisa
Maziere, Nicole
Cass, Emily
Carracedo, Alejandra Doce
Carlucci, Nicola
Holmes, Anthony
Massey, Hannah
Adeniji, Kayode
Agranoff, Daniel
Agwuh, Ken
Ail, Dhiraj
Alegria, Ana
Angus, Brian
Ashish, Abdul
Atkinson, Dougal
Bari, Shahedal
Barlow, Gavin
Barnass, Stella
Barrett, Nicholas
Bassford, Christopher
Baxter, David
Beadsworth, Michael
Bernatoniene, Jolanta
Berridge, John
Best, Nicola
Bothma, Pieter
Brealey, David
Brittain-Long, Robin
Bulteel, Naomi
Burden, Tom
Burtenshaw, Andrew
Caruth, Vikki
Chadwick, David
Chambler, Duncan
Chee, Nigel
Child, Jenny
Chukkambotla, Srikanth
Clark, Tom
Collini, Paul
Cosgrove, Catherine
Cupitt, Jason
Cutino-Moguel, Maria-Teresa
Dark, Paul
Dawson, Chris
Dervisevic, Samir
Donnison, Phil
Douthwaite, Sam
DuRand, Ingrid
Dushianthan, Ahilanadan
Dyer, Tristan
Evans, Cariad
Eziefula, Chi
Fegan, Chrisopher
Finn, Adam
Fullerton, Duncan
Garg, Sanjeev
Garg, Sanjeev
Garg, Atul
Gkrania-Klotsas, Effrossyni
Godden, Jo
Goldsmith, Arthur
Graham, Clive
Hardy, Elaine
Hartshorn, Stuart
Harvey, Daniel
Havalda, Peter
Hawcutt, Daniel B
Hobrok, Maria
Hodgson, Luke
Hormis, Anil
Jacobs, Michael
Jain, Susan
Jennings, Paul
Kaliappan, Agilan
Kasipandian, Vidya
Kegg, Stephen
Kelsey, Michael
Kendall, Jason
Kerrison, Caroline
Kerslake, Ian
Koch, Oliver
Koduri, Gouri
Koshy, George
Laha, Shondipon
Laird, Steven
Larkin, Susan
Leiner, Tamas
Lillie, Patrick
Limb, James
Linnett, Vanessa
Little, Jeff
MacMahon, Michael
MacNaughton, Emily
Mankregod, Ravish
Masson, Huw
Matovu, Elijah
McCullough, Katherine
McEwen, Ruth
Meda, Manjula
Mills, Gary
Minton, Jane
Mirfenderesky, Mariyam
Mohandas, Kavya
Mok, Quen
Moon, James
Moore, Elinoor
Morgan, Patrick
Morris, Craig
Mortimore, Katherine
Moses, Samuel
Mpenge, Mbiye
Mulla, Rohinton
Murphy, Michael
Nagel, Megan
Nagarajan, Thapas
Nelson, Mark
Otahal, Igor
Pais, Mark
Panchatsharam, Selva
Paraiso, Hassan
Patel, Brij
Pattison, Natalie
Pepperell, Justin
Peters, Mark
Phull, Mandeep
Pintus, Stefania
Pooni, Jagtur
Post, Frank
Price, David
Prout, Rachel
Rae, Nikolas
Reschreiter, Henrik
Reynolds, Tim
Richardson, Neil
Roberts, Mark
Roberts, Devender
Rose, Alistair
Rousseau, Guy
Ryan, Brendan
Saluja, Taranprit
Shah, Aarti
Shanmuga, Prad
Sharma, Anil
Shawcross, Anna
Sizer, Jeremy
Shankar-Hari, Manu
Smith, Richard
Snelson, Catherine
Spittle, Nick
Staines, Nikki
Stambach, Tom
Stewart, Richard
Subudhi, Pradeep
Szakmany, Tamas
Tatham, Kate
Thomas, Jo
Thompson, Chris
Thompson, Robert
Tridente, Ascanio
Tupper-Carey, Darell
Twagira, Mary
Ustianowski, Andrew
Vallotton, Nick
Vincent-Smith, Lisa
Visuvanathan, Shico
Vuylsteke, Alan
Waddy, Sam
Wake, Rachel
Walden, Andrew
Welters, Ingeborg
Whitehouse, Tony
Whittaker, Paul
Whittington, Ashley
Wijesinghe, Meme
Williams, Martin
Wilson, Lawrence
Wilson, Sarah
Winchester, Stephen
Wiselka, Martin
Wolverson, Adam
Wooton, Daniel G
Workman, Andrew
Yates, Bryan
Young, Peter
… (more) - Abstract:
- Summary: Background: Studies of patients admitted to hospital with COVID-19 have found varying mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid use. Using data from a national, multicentre, prospective cohort, we aimed to characterise people with COVID-19 admitted to hospital with underlying respiratory disease, assess the level of care received, measure in-hospital mortality, and examine the effect of inhaled corticosteroid use. Methods: We analysed data from the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study. All patients admitted to hospital with COVID-19 across England, Scotland, and Wales between Jan 17 and Aug 3, 2020, were eligible for inclusion in this analysis. Patients with asthma, chronic pulmonary disease, or both, were identified and stratified by age (<16 years, 16–49 years, and ≥50 years). In-hospital mortality was measured by use of multilevel Cox proportional hazards, adjusting for demographics, comorbidities, and medications (inhaled corticosteroids, short-acting β-agonists [SABAs], and long-acting β-agonists [LABAs]). Patients with asthma who were taking an inhaled corticosteroid plus LABA plus another maintenance asthma medication were considered to have severe asthma. Findings: 75 463 patients from 258 participating health-care facilities were included in this analysis: 860 patients younger than 16 years (74 [8·6%]Summary: Background: Studies of patients admitted to hospital with COVID-19 have found varying mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid use. Using data from a national, multicentre, prospective cohort, we aimed to characterise people with COVID-19 admitted to hospital with underlying respiratory disease, assess the level of care received, measure in-hospital mortality, and examine the effect of inhaled corticosteroid use. Methods: We analysed data from the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) WHO Clinical Characterisation Protocol UK (CCP-UK) study. All patients admitted to hospital with COVID-19 across England, Scotland, and Wales between Jan 17 and Aug 3, 2020, were eligible for inclusion in this analysis. Patients with asthma, chronic pulmonary disease, or both, were identified and stratified by age (<16 years, 16–49 years, and ≥50 years). In-hospital mortality was measured by use of multilevel Cox proportional hazards, adjusting for demographics, comorbidities, and medications (inhaled corticosteroids, short-acting β-agonists [SABAs], and long-acting β-agonists [LABAs]). Patients with asthma who were taking an inhaled corticosteroid plus LABA plus another maintenance asthma medication were considered to have severe asthma. Findings: 75 463 patients from 258 participating health-care facilities were included in this analysis: 860 patients younger than 16 years (74 [8·6%] with asthma), 8950 patients aged 16–49 years (1867 [20·9%] with asthma), and 65 653 patients aged 50 years and older (5918 [9·0%] with asthma, 10 266 [15·6%] with chronic pulmonary disease, and 2071 [3·2%] with both asthma and chronic pulmonary disease). Patients with asthma were significantly more likely than those without asthma to receive critical care (patients aged 16–49 years: adjusted odds ratio [OR] 1·20 [95% CI 1·05–1·37]; p=0·0080; patients aged ≥50 years: adjusted OR 1·17 [1·08–1·27]; p<0·0001), and patients aged 50 years and older with chronic pulmonary disease (with or without asthma) were significantly less likely than those without a respiratory condition to receive critical care (adjusted OR 0·66 [0·60–0·72] for those without asthma and 0·74 [0·62–0·87] for those with asthma; p<0·0001 for both). In patients aged 16–49 years, only those with severe asthma had a significant increase in mortality compared to those with no asthma (adjusted hazard ratio [HR] 1·17 [95% CI 0·73–1·86] for those on no asthma therapy, 0·99 [0·61–1·58] for those on SABAs only, 0·94 [0·62–1·43] for those on inhaled corticosteroids only, 1·02 [0·67–1·54] for those on inhaled corticosteroids plus LABAs, and 1·96 [1·25–3·08] for those with severe asthma). Among patients aged 50 years and older, those with chronic pulmonary disease had a significantly increased mortality risk, regardless of inhaled corticosteroid use, compared to patients without an underlying respiratory condition (adjusted HR 1·16 [95% CI 1·12–1·22] for those not on inhaled corticosteroids, and 1·10 [1·04–1·16] for those on inhaled corticosteroids; p<0·0001). Patients aged 50 years and older with severe asthma also had an increased mortality risk compared to those not on asthma therapy (adjusted HR 1·24 [95% CI 1·04–1·49]). In patients aged 50 years and older, inhaled corticosteroid use within 2 weeks of hospital admission was associated with decreased mortality in those with asthma, compared to those without an underlying respiratory condition (adjusted HR 0·86 [95% CI 0·80−0·92]). Interpretation: Underlying respiratory conditions are common in patients admitted to hospital with COVID-19. Regardless of the severity of symptoms at admission and comorbidities, patients with asthma were more likely, and those with chronic pulmonary disease less likely, to receive critical care than patients without an underlying respiratory condition. In patients aged 16 years and older, severe asthma was associated with increased mortality compared to non-severe asthma. In patients aged 50 years and older, inhaled corticosteroid use in those with asthma was associated with lower mortality than in patients without an underlying respiratory condition; patients with chronic pulmonary disease had significantly increased mortality compared to those with no underlying respiratory condition, regardless of inhaled corticosteroid use. Our results suggest that the use of inhaled corticosteroids, within 2 weeks of admission, improves survival for patients aged 50 years and older with asthma, but not for those with chronic pulmonary disease. Funding: National Institute for Health Research, Medical Research Council, NIHR Health Protection Research Units in Emerging and Zoonotic Infections at the University of Liverpool and in Respiratory Infections at Imperial College London in partnership with Public Health England. … (more)
- Is Part Of:
- Lancet. Volume 9:Issue 7(2021)
- Journal:
- Lancet
- Issue:
- Volume 9:Issue 7(2021)
- Issue Display:
- Volume 9, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 9
- Issue:
- 7
- Issue Sort Value:
- 2021-0009-0007-0000
- Page Start:
- 699
- Page End:
- 711
- Publication Date:
- 2021-07
- Subjects:
- Respiratory organs -- Diseases -- Periodicals
616.2005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/22132600 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/S2213-2600(21)00013-8 ↗
- Languages:
- English
- ISSNs:
- 2213-2600
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.095000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17418.xml